Skip to content

Partial splenic embolization in the treatment of patients with hypersplenism by transradial or transfemoral approach: A prospective randomized controlled trial

Partial splenic embolization in the treatment of patients with hypersplenism by transradial or transfemoral approach: A prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15005768
Enrollment
Unknown
Registered
2015-01-03
Start date
2011-01-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypersplenism

Interventions

R-PSE group:Partial splenic embolization was used to treat the patients with hypersplenism by transradial approach.
F-PSE group:Partial splenic embolization was used to treat the patients with hypersplenism by transfemoral approach.

Sponsors

The first Affiliated Hospital of Henan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to 72 Years

Inclusion criteria

Inclusion criteria: 1. In accordance with hypersplenism diagnosis standard; 2. Age from 38 to 72 years, men and women not limited; 3. Child-pugh score of Liver function: A, B; 4. Hepatitis Type: HBV, HCV; 5. for family members or guardian or legal representative of a written informed consent; 6. Iodine allergy test show negative.

Exclusion criteria

Exclusion criteria: 1. patients do not meet the diagnostic hypersplenism; 2. have serious body disease, epilepsy, heart failure, severe cirrhosis, severe acute or chronic renal failure, sever diabetes, and other serious nervous system, heart, liver, kidney, endocrine, blood system and other body disease; 3. Who are allergic to iodine; 4. Child-pugh score of Liver function: C

Design outcomes

Primary

MeasureTime frame
vascular puncture success rate;Surgery success rate;operative time;X-ray exposure time;Length of hospital stay;Hospitalization expenses;

Countries

China

Contacts

Public ContactZhao Zhijun
zhao008009zhijun@gmail.com+86 13503786606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026